Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
MDWD Stock — Mediwound Ltd
Mediwound Ltd (MDWD)
Updated October 16, 2026.
MDWD is a Stock. Total return is -90.2% over the past 12.6 years, 493.2 points behind SPY at 403.0%.
MediWound Ltd. is a biopharmaceutical company developing bio-therapeutic and non-surgical solutions for tissue repair and regeneration, with its lead product NexoBrid approved for eschar removal in burn patients, along with pipeline candidates for chronic wounds and skin cancers. The company does not currently distribute dividends to shareholders. MediWound appeals primarily to growth-oriented investors seeking exposure to specialized medical technology rather than income-focused investors.
MDWD performance versus SPY
Price and return data through 2026-10-16.
Total return is -90.2% over the past 12.6 years, 493.2 points behind SPY at 403.0%. Over the past year its total return — price change plus distributions reinvested — is -39.1%. Its deepest 1-year drawdown was 39.8%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -10.4% | — |
| 3M | -18.9% | — |
| 6M | -30.7% | — |
| YTD | -35.8% | — |
| 1Y | -39.1% | — |
| 2Y CAGR | — | -18.80% |
| 3Y CAGR | — | 10.40% |
| 5Y CAGR | — | -13.10% |
| 10Y CAGR | — | -13.10% |
| Since inception (12.6 years) | -90.2% | -16.90% |
MDWD key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 03/20/2014
- Distribution frequency
- None
- Last close
- $11.85 (as of 2026-10-16)
- Market cap
- $152,986,794
- Average volume
- 33443.0
- Beta
- 0.094
- Payout ratio
- 0.0%
- Forward P/E
- 34.965
- EPS
- $-2.17
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
MDWD risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 39.8%.
Who may consider MDWD — and who may not
It is a weaker fit for investors who need monthly cash flow (MDWD does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on MDWD
Frequently asked questions
Does MDWD pay monthly?
No. MDWD does not currently distribute.
When does MDWD pay a dividend?
MDWD does not currently distribute.
How has MDWD performed?
Total return is -90.2% over the past 12.6 years, 493.2 points behind SPY at 403.0%. Over the past year its total return — price change plus distributions reinvested — is -39.1%. Its deepest 1-year drawdown was 39.8%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.